Mild Shock Therapy May Ease Anxiety and Depression, but Not Chronic Pain Mild Shock Therapy May Ease Anxiety and Depression, but Not Chronic Pain

People with anxiety and depression might feel a little better after they get mild electric shock therapy, but it ’ s unclear how much it will help or whether this treatment might ease other conditions, researchers say.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news

Related Links:

This study aimed to: (1) meta-analytically quantify the relationship between catastrophizing and pain and functional/psychosocial outcomes (functional disability/physical functioning, anxiety, depression, and QOL) in children with chronic pain, and (2) examine potential moderators of these relationships. Using a random-effects model, a total of 111 effect sizes from 38 studies were analyzed. Effect sizes ranged from medium to large, with anxiety, depression, and QOL demonstrating a strong association with catastrophizing. Pain intensity and physical disability had a moderate association with catastrophizing. These relation...
Source: Pain - Category: Anesthesiology Tags: Systematic Reviews and Meta-Analyses Source Type: research
The left dorsolateral prefrontal cortex (DLPFC) is involved in the experience and modulation of pain, and may be an important node linking pain and cognition. Repetitive transcranial magnetic stimulation (rTMS) to the left DLPFC can reduce chronic and experimental pain. However, whether left DLPFC rTMS can influence the development of chronic pain is unknown. Using repeated intramuscular injection of nerve growth factor to induce the development of sustained muscle pain (lasting weeks), 30 healthy individuals were randomized to receive 5 consecutive daily treatments of active or sham left DLPFC rTMS, starting before the fi...
Source: Pain - Category: Anesthesiology Tags: Research Paper Source Type: research
In this study, we evaluated the efficacy of the tricyclic antidepressant desipramine (DMI, a noradrenaline reuptake inhibitor) in preventing or relieving the noradrenergic impairment induced by neuropathic pain. The treatment started before or after the onset of the anxiodepressive phenotype (“early or late treatment”) in adult rats subjected to chronic sciatic constriction. Electrophysiological and western blotting assays showed LC dysfunction (increased bursting activity, alpha2-adrenoceptor sensitivity, tyrosine hydroxylase, and noradrenaline transporter expression) in chronic constriction injury at long ter...
Source: Pain - Category: Anesthesiology Tags: Research Paper Source Type: research
The scale of interpersonal violence against women in the United States is striking; an estimated 1 in 3 women have been sexually assaulted, and 1 in 4 have been victims of intimate partner violence (IPV). The consequences include increased risk for mental and physical health problems including depression, anxiety, eating disorders, posttraumatic stress disorder, addiction, injury, chronic pain, disability, and possibly cardiovascular disease. Although research typically focuses on women of reproductive age, IPV and sexual assault also affect older women.
Source: JAMA Internal Medicine - Category: Internal Medicine Source Type: research
ConclusionThis study suggests that, of those patients with chronic pain who choose to attend pain education, more educated patients are more likely to improve their pain biology knowledge after a pain education session.This article is protected by copyright. All rights reserved.
Source: Pain Practice - Category: Anesthesiology Authors: Tags: Original Article Source Type: research
Publication date: Available online 16 November 2018Source: SexologiesAuthor(s): I. Berrahal, A. Maamri, B. Ayadi, Y. El Kissi, M. HaddadRésuméIntroductionLe recours aux antalgiques opioïdes au long cours peut contribuer à l’apparition de dysfonctions sexuelles (DS) féminines. Ainsi, nous avons mené une étude afin de déterminer l’impact des antalgiques opioïdes sur la sexualité féminine.MéthodesIl s’agissait d’une étude de type cas-témoin, auprès de 36 femmes, âgées entre 18 et ...
Source: Sexologies - Category: Sexual Medicine Source Type: research
ConclusionThe study findings provide evidence for the reliability and validity of 2- and 4-item versions of the Japanese Pain Self-Efficacy Questionnaire for use in clinical and research settings.
Source: Journal of Anesthesia - Category: Anesthesiology Source Type: research
Authors: Domhardt M, Steubl L, Baumeister H Abstract This meta-review integrates the current meta-analysis literature on the efficacy of internet- and mobile-based interventions (IMIs) for mental disorders and somatic diseases in children and adolescents. Further, it summarizes the moderators of treatment effects in this age group. Using a systematic literature search of PsycINFO and MEDLINE/PubMed, we identified eight meta-analyses (N = 8,417) that met all inclusion criteria. Current meta-analytical evidence of IMIs exists for depression (range of standardized mean differences, SMDs = .16 to .76; 95 % CI: -.12 to ...
Source: Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie - Category: Child Development Tags: Z Kinder Jugendpsychiatr Psychother Source Type: research
The management of co-occurring opioid use disorder and chronic pain is challenging (Dhingra et al., 2013; Wachholtz et al., 2011). Unrelieved pain in patients with opioid use disorder is associated with medical and nonmedical use of opioids (often to self-medicate), sleep disturbance, trauma, anxiety, depression, personality disorders, and decreased dispositional optimism (Barry et al., 2009a; Barry et al., 2009b; Beitel et al., 2015; Beitel et al., 2012; Peles et al., 2009; Rosenblum et al., 2003).
Source: Drug and Alcohol Dependence - Category: Addiction Authors: Tags: Full length article Source Type: research
Chronic Fatigue Syndrome, also known as Myalgic Encephalomyelitis (CFS/ME) is a complex and extremely debilitating chronic medical condition [1]. Its etiology remains unknown. No clinically established diagnostic tests exist; nor are any effective FDA-approved drugs available for treatment currently. Its symptoms are persistent disabling fatigue for more than six months and a constellation of symptoms such as multi-joint pain, myalgia, unrefreshing sleep, impaired memory and/or concentration, new headaches, anxiety/depression, autonomic dysfunction and post-exertional malaise that does not improve with rest.
Source: Prostaglandins, Leukotrienes and Essential Fatty Acids - Category: Biomedical Science Authors: Source Type: research
More News: Anxiety | Chronic Pain | Depression | Health | Pain | Psychiatry